Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.

× No keyword cloud information.

51 in total

1. DOWN'S SYNDROME WITH NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO HLA-A2 ANTIBODY.

Authors: Toshihiko Nakamura; Tomoaki Nomura; Takashi Kamohara; Hidehiro Takahashi; Daisuke Hatanaka; Michiko Kusakari; Mari Nakamura; Kinuyo Kawabata; Hitoshi Ohto
Journal: Fukushima J Med Sci Date: 2015-12-03

2. Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group.

Authors: Hiroaki Goto; Takeshi Inukai; Hiroyasu Inoue; Chitose Ogawa; Takashi Fukushima; Miharu Yabe; Akira Kikuchi; Kazutoshi Koike; Keitaro Fukushima; Keiichi Isoyama; Tomohiro Saito; Akira Ohara; Ryoji Hanada; Jiro Iwamoto; Noriko Hotta; Yoshihisa Nagatoshi; Jun Okamura; Masahiro Tsuchida
Journal: Int J Hematol Date: 2011-02-01 Impact factor: 2.490

3. Some dynamic aspects of hematopoietic stem cells.

Authors: David Dingli; Jorge M Pacheco
Journal: Stem Cell Rev Date: 2008 Impact factor: 5.739

4. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.

Authors: Su Han Lum; Soo Sin Choong; Shekhar Krishnan; Zulqarnain Mohamed; Hany Ariffin
Journal: Singapore Med J Date: 2016-06 Impact factor: 1.858

Review 5. Malignancy in children with trisomy 21.

Authors: Karen R Rabin; James A Whitlock
Journal: Oncologist Date: 2009-01-28

6. Leukemogenesis caused by incapacitated GATA-1 function.

Authors: Ritsuko Shimizu; Takashi Kuroha; Osamu Ohneda; Xiaoqing Pan; Kinuko Ohneda; Satoru Takahashi; Sjaak Philipsen; Masayuki Yamamoto
Journal: Mol Cell Biol Date: 2004-12 Impact factor: 4.272

7. Epidemiologic study of residential proximity to transmission lines and childhood cancer in California: description of design, epidemiologic methods and study population.

Authors: Leeka Kheifets; Catherine M Crespi; Chris Hooper; Sona Oksuzyan; Myles Cockburn; Thomas Ly; Gabor Mezei
Journal: J Expo Sci Environ Epidemiol Date: 2013-09-18 Impact factor: 5.563

8. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.

Authors: Hirokazu Kanegane; Sayaka Watanabe; Keiko Nomura; Gang Xu; Etsuro Ito; Toshio Miyawaki
Journal: Int J Hematol Date: 2007-10 Impact factor: 2.490

9. Trisomy 21 enhances human fetal erythro-megakaryocytic development.

Authors: Stella T Chou; Joanna B Opalinska; Yu Yao; Myriam A Fernandes; Anna Kalota; John S J Brooks; John K Choi; Alan M Gewirtz; Gwenn-ael Danet-Desnoyers; Richard L Nemiroff; Mitchell J Weiss
Journal: Blood Date: 2008-09-23 Impact factor: 22.113

10. Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.

Authors: Maureen M O'Brien; Jeffrey W Taub; Myron N Chang; Gita V Massey; Kimo C Stine; Susana C Raimondi; David Becton; Yaddanapudi Ravindranath; Gary V Dahl
Journal: J Clin Oncol Date: 2008-01-20 Impact factor: 44.544